Diagnosis and Management of Cardiac Sarcoidosis

Progress in Cardiovascular Diseases

Volumn 52, Issue 4, 2010, Pages 336-346

  Dubrey, Simon W ^a   Falk, Rodney H ^b  

^a HILLINGDON HOSPITAL   (United Kingdom)

^b HARVARD VANGUARD MEDICAL ASSOCIATES   (United States)

Author keywords

Cardiac MRI; Cardiac PET scan; Cardiac sarcoidosis; Cardiomyopathy; Endomyocardial biopsy; Sarcoidosis

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; DIURETIC AGENT; FLUORODEOXYGLUCOSE F 18; GALLIUM 67; INFLIXIMAB; METHOTREXATE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PREDNISONE; STEROID; THALLIUM 201;

ARTICLE; CARDIOMYOPATHY; CATHETER ABLATION; CLINICAL FEATURE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CRYPTOCOCCOSIS; DEFIBRILLATION; DIAGNOSTIC IMAGING; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; DRUG MECHANISM; DRUG MEGADOSE; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; HEART ARRHYTHMIA; HEART BLOCK; HEART DEATH; HEART DISEASE; HEART MUSCLE BIOPSY; HEART SCINTISCANNING; HEART TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; HYPERGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; INFECTION SENSITIVITY; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; MYOCARDITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIMAL DRUG DOSE; OSTEOPOROSIS; RECOMMENDED DRUG DOSE; RECURRENT DISEASE; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SARCOIDOSIS; SENSITIVITY AND SPECIFICITY; SIDE EFFECT; THORAX RADIOGRAPHY; WEIGHT GAIN;

ADULT; AGED; BIOPSY; CARDIOMYOPATHIES; CARDIOVASCULAR AGENTS; DIAGNOSTIC IMAGING; FEMALE; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SARCOIDOSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 73049091191     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcad.2009.11.010     Document Type: Article

References (57)

1. Akbar J.J., Meyer C.A., Shipley R.T., et al. Cardiopulmonary imaging in sarcoidosis. Clin Chest Med 29 (2008) 429-443
2. Baughman R.P., Teirstein A.S., Judson M.A., et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 15 (2001) 1885-1889
3. Lodha S., Sanchez M., and Prystowsky S. Sarcoidosis of the skin: a review for the pulmonologist. Chest 136 (2009) 583-596
4. Brown M.L., Reeder G., Unni K.K., et al. Intraoperative diagnosis of isolated cardiac sarcoid. Heart Lung Circ 16 (2007) 315-317
5. Roberts W.C., McAllister Jr. H.A., and Ferrans V.J. Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 2). Am J Med 63 (1977) 86-108
6. Silverman K.J., Hutchins G.M., and Bulkley B.H. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 58 (1978) 1204-1211
7. Tavora F., Cresswell N., Li L., et al. Comparison of necropsy findings in patients with sarcoidosis dying suddenly from cardiac sarcoidosis versus dying suddenly from other causes. Am J Cardiol 104 (2009) 571-577
8. Rybicki B.A., Major M., Popovich Jr. J., et al. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 145 (1997) 234-241
9. Barnard J., Rose C., Newman L., et al. Job and industry classifications associated with sarcoidosis in A Case-Control Etiologic Study of Sarcoidosis (ACCESS). J Occup Environ Med 47 (2005) 226-234
10. Newman L.S., Rose C.S., Bresnitz E.A., et al. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med 170 (2004) 1324-1330
11. Izbicki G., Chavko R., Banauch G.I., et al. World Trade Center "sarcoid-like" granulomatous pulmonary disease in New York City Fire Department rescue workers. Chest 131 (2007) 1414-1423
12. Kucera G.P., Rybicki B.A., Kirkey K.L., et al. Occupational risk factors for sarcoidosis in African-American siblings. Chest 123 (2003) 1527-1535
13. Rybicki B.A., Maliarik M.J., Major M., et al. Epidemiology, demographics, and genetics of sarcoidosis. Semin Respir Infect 13 (1998) 166-173
14. Sverrild A., Backer V., Kyvik K.O., et al. Heredity in sarcoidosis: a registry-based twin study. Thorax 63 (2008) 894-896
15. Butany J., Bahl N.E., Morales K., et al. The intricacies of cardiac sarcoidosis: a case report involving the coronary arteries and a review of the literature. Cardiovasc Pathol 15 (2006) 222-227
16. Dempsey O.J., Paterson E.W., Kerr K.M., et al. Sarcoidosis. BMJ b3206 (2009) 339
17. Okura Y., Dec G.W., Hare J.M., et al. A clinical and histopathologic comparison of cardiac sarcoidosis and idiopathic giant cell myocarditis. J Am Coll Cardiol 41 (2003) 322-329
18. Sekiguchi M., Numao Y., Imai M., et al. Clinical and histopathological profile of sarcoidosis of the heart and acute idiopathic myocarditis. Concepts through a study employing endomyocardial biopsy. I. Sarcoidosis. Jpn Circ J 44 (1980) 249-263
19. Iwai K., Sekiguti M., Hosoda Y., et al. Racial difference in cardiac sarcoidosis incidence observed at autopsy. Sarcoidosis 11 (1994) 26-31
20. Fine R.M. The mechanism of hypercalcemia in sarcoidosis. Int J Dermatol 26 (1987) 22-23
21. Gardner D.G. Hypercalcemia and sarcoidosis-another piece of the puzzle falls into place. Am J Med 110 (2001) 736-737
22. Ainslie G.M., and Benatar S.R. Serum angiotensin converting enzyme in sarcoidosis: sensitivity and specificity in diagnosis: correlations with disease activity, duration, extra-thoracic involvement, radiographic type and therapy. Q J Med 55 (1985) 253-270
23. Biller H., Zissel G., Ruprecht B., et al. Genotype-corrected reference values for serum angiotensin-converting enzyme. Eur Respir J 28 (2006) 1085-1090
24. Soejima K., and Yada H. The work-up and management of patients with apparent or subclinical cardiac sarcoidosis: with emphasis on the associated heart rhythm abnormalities. J Cardiovasc Electrophysiol 20 (2009) 578-583
25. Ardehali H., Howard D.L., Hariri A., et al. A positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initially unexplained cardiomyopathy. Am Heart J 150 (2005) 459-463
26. Koplan B.A., Soejima K., Baughman K., et al. Refractory ventricular tachycardia secondary to cardiac sarcoid: electrophysiologic characteristics, mapping, and ablation. Heart Rhythm 3 (2006) 924-929
27. Uemura A., Morimoto S., Kato Y., et al. Relationship between basal thinning of the interventricular septum and atrioventricular block in patients with cardiac sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 22 (2005) 63-65
28. Matsumori A., Hara M., Nagai S., et al. Hypertrophic cardiomyopathy as a manifestation of cardiac sarcoidosis. Jpn Circ J 64 (2000) 679-683
29. Yazaki Y., Isobe M., Hayasaka M., et al. Cardiac sarcoidosis mimicking hypertrophic cardiomyopathy: clinical utility of radionuclide imaging for differential diagnosis. Jpn Circ J 62 (1998) 465-468
30. Smedema J.P. Tissue Doppler imaging in cardiac sarcoidosis. Eur J Echocardiogr 9 (2008) 579-580
31. Okayama K., Kurata C., Tawarahara K., et al. Diagnostic and prognostic value of myocardial scintigraphy with thallium-201 and gallium-67 in cardiac sarcoidosis. Chest 107 (1995) 330-334
32. Tawarahara K., Kurata C., Okayama K., et al. Thallium-201 and gallium 67 single photon emission computed tomographic imaging in cardiac sarcoidosis. Am Heart J 124 (1992) 1383-1384
33. Hirose Y., Ishida Y., Hayashida K., et al. Myocardial involvement in patients with sarcoidosis. An analysis of 75 patients. Clin Nucl Med 19 (1994) 522-526
34. Nakazawa A., Ikeda K., Ito Y., et al. Usefulness of dual 67Ga and 99mTc-sestamibi single-photon-emission CT scanning in the diagnosis of cardiac sarcoidosis. Chest 126 (2004) 1372-1376
35. Tadamura E., Yamamuro M., Kubo S., et al. Effectiveness of delayed enhanced MRI for identification of cardiac sarcoidosis: comparison with radionuclide imaging. AJR Am J Roentgenol 185 (2005) 110-115
36. Radulescu B., Imperiale A., Germain P., et al. Severe ventricular arrhythmias in a patient with cardiac sarcoidosis: insights from MRI and PET imaging and importance of early corticosteroid therapy. Eur Heart J (2009) (in press)
37. Doughan A.R., and Williams B.R. Cardiac sarcoidosis. Heart 92 (2006) 282-288
38. Smedema J.P., Snoep G., van Kroonenburgh M.P., et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 45 (2005) 1683-1690
39. Smedema J.P., Truter R., de Klerk P.A., et al. Cardiac sarcoidosis evaluated with gadolinium-enhanced magnetic resonance and contrast-enhanced 64-slice computed tomography. Int J Cardiol 112 (2006) 261-263
40. Mehta D., Lubitz S.A., Frankel Z., et al. Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing. Chest 133 (2008) 1426-1435
41. Braun J.J., Kessler R., Constantinesco A., et al. 18F-FDG PET/CT in sarcoidosis management: review and report of 20 cases. Eur J Nucl Med Mol Imaging 35 (2008) 1537-1543
42. Ohira H., Tsujino I., Ishimaru S., et al. Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis. Eur J Nucl Med Mol Imaging 35 (2008) 933-941
43. Sugisaki K., Yamaguchi T., Nagai S., et al. Clinical characteristics of 195 Japanese sarcoidosis patients treated with oral corticosteroids. Sarcoidosis Vasc Diffuse Lung Dis 20 (2003) 222-226
44. Vasaiwala S.C., Finn C., Delpriore J., et al. Prospective study of cardiac sarcoid mimicking arrhythmogenic right ventricular dysplasia. J Cardiovasc Electrophysiol 20 (2009) 473-476
45. Kim J.S., Judson M.A., Donnino R., et al. Cardiac sarcoidosis. Am Heart J 157 (2009) 9-21
46. Paramothayan N.S., and Jones P.W. Corticosteroids for pulmonary sarcoidosis. Cochrane Database Syst Rev (2000) CD001114
47. Chiu C.Z., Nakatani S., Zhang G., et al. Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis. Am J Cardiol 95 (2005) 143-146
48. Chapelon-Abric C., de Zuttere D., Duhaut P., et al. Cardiac sarcoidosis: a retrospective study of 41 cases. Medicine 83 (2004) 315-334
49. Yazaki Y., Isobe M., Hiroe M., et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol 88 (2001) 1006-1010
50. Keijsers R.G., Verzijlbergen J.F., van Diepen D.M., et al. 18F-FDG PET in sarcoidosis: an observational study in 12 patients treated with infliximab. Sarcoidosis Vasc Diffuse Lung Dis 25 (2008) 143-149
51. Barnabe C., McMeekin J., Howarth A., et al. Successful treatment of cardiac sarcoidosis with infliximab. J Rheumatol 35 (2008) 1686-1687
52. Judson M.A., Baughman R.P., Costabel U., et al. Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial. Eur Respir J 31 (2008) 1189-1196
53. Uthman I., Touma Z., and Khoury M. Cardiac sarcoidosis responding to monotherapy with infliximab. Clin Rheumatol 26 (2007) 2001-2003
54. Arnaud L., Sene D., Costedoat-Chalumeau N., et al. Disseminated cryptococcal infection and anti-tumor necrosis factor-alpha treatment for refractory sarcoidosis: an expected association?. J Rheumatol 36 (2009) 462-463
55. Zaidi A.R., Zaidi A., and Vaitkus P.T. Outcome of heart transplantation in patients with sarcoid cardiomyopathy. J Heart Lung Transplant 26 (2007) 714-717
56. Milman N., Andersen C.B., Mortensen S.A., et al. Cardiac sarcoidosis and heart transplantation: a report of four consecutive patients. Sarcoidosis Vasc Diffuse Lung Dis 25 (2008) 51-59
57. Yager J.E., Hernandez A.F., Steenbergen C., et al. Recurrence of cardiac sarcoidosis in a heart transplant recipient. J Heart Lung Transplant 24 (2005) 1988-1990